Profits Prove Elusive in Madagascar Sapphire Rush
630448
ILAKAKA, Madagascar  - Jean Railala plunges his  rectangular sieve into the chocolate-colored river.
520589
Investors are discouraged after it releases the latest data for its top drug.
294610
The stock is revived, but the business remains iffy.
491204
The telecom's results can't quite connect with Wall Street's expectations.
348955
The stock looks reasonably valued but some core businesses are struggling to grow.
72590
The credit card contender continues to toil in obscurity.
70739
But a rival bid and continuing turbulence in financial markets left the outcome of the worldâs biggest banking battle still uncertain.
184637
Big valuation, leaky moat, and a large shareholder fleeing. Any takers?
446413
Harmony, the listed gold miner, has not put a final figure on how much it will have to spend on its hostile bid for local rival Gold Fields.
280221
The pipeline drugs hold promise, but it will be a while before the company shows a profit.
137776
Wall Street was unsurprised to hear of more takeover speculation in the mining sector on Tuesday, but despite a surge in Alcoa's stock price, few analysts believed the U.S. aluminum giant was about to be gobbled up.
363785
Sales of the multiple sclerosis drug are picking up, but probably can't grow into the stock's valuation.
32605
Despite its ongoing fight to thwart a takeover, investors still got to celebrate stronger-than-expected earnings. Can this be sustained?
545553
Merchants say sales arm of popular auction site hasn't drawn expected online crowds.
83802
The company has been rebuffed in Australia as it tries to grow.
745053
The strategy of fighting AIDS in Africa with questionable generic drugs made in developing countries now lies in shambles as an Indian company withdrew its medicines last week because it can&#39;t guarantee they are potent enough.
607151
Flamel might be earning more than had been calculated from its lead drug, but the company still isn't profitable.